Washington University in St. Louis

Optical biopsy of nasal cavity cancer with confocal laser endomicroscopy – a pilot study (2026) Müller-Diesing F, Sievert M, Panuganti BA, Aubreville M, Porsche N, Hackenberg S, Stöth M, et al. Journal article Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy (2026) Möhn N, Grote-Levi L, Bonifacius A, Tischer-Zimmermann S, Nay S, Jendretzky KF, Sassmann ML, et al. Journal article Noise in the diagnosis of epilepsy by experts (2026) Nascimento FA, McLaren JR, Zhao W, Katyal R, Sheikh IS, Kong WY, Aljaafari D, et al. Journal article Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized Trial (2026) Agarwal R, Green JB, Heerspink HJ, McGill JB, Mottl A, Nangaku M, Rosenstock J, et al. Journal article Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial (2026) Vaduganathan M, Green JB, Heerspink HJ, Kim SG, Mann JF, McGill JB, Mottl A, et al. Journal article Performance Modeling and Improvements on the GRB Source Localization Streaming Pipeline Aboard the Antarctic Demonstrator for the Advanced Particle-Astrophysics Telescope (ADAPT) (2025) Htet Y, Sudvarg M, Yang H, Buhler J, Chamberlain R, Chen W, Buckley J, et al. Conference contribution Attitudes of female carriers of X-linked hypohidrotic ectodermal dysplasia towards prenatal treatment and their decisions during a pregnancy with a male fetus (2025) Schneider H, Schneider M, Lia M, Grange DK, Hadj-Rabia S, Clarke A, Fete M, et al. Journal article Unveiling blazar synchrotron emission: A multiwavelength polarimetric study of high-synchrotron and low-synchrotron peaked populations (2025) Capecchiacci S, Liodakis I, Middei R, Kim DE, Di Gesu L, Agudo I, Agís-González B, et al. Journal article Unprecedentedly bright X-ray flaring in Cygnus X-1 observed by INTEGRAL (2025) Thalhammer P, Bouchet T, Rodriguez J, Cangemi F, Pottschmidt K, Green DA, Rhodes L, et al. Journal article Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial) (2025) Agarwal R, Green JB, Heerspink HJ, Mann JF, McGill JB, Mottl AK, Nangaku M, et al. Journal article